FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> FDA approval | Johnson & Johnson

J&J's Topamax helps alcoholics quit

Tools

What do you call a migraine drug that could help alcoholics quit drinking? A big-time marketing opportunity--if it weren't going off patent next year.

A new study shows that the Johnson & Johnson remedy Topamax, used in epilepsy and migraine, can help alcoholics stop craving liquor. The study was funded in part by the company, but it says it doesn't plan to seek FDA approval for its use against alcoholism. Doctors could prescribe it off-label, however.

J&J didn't put out a press release touting the research, perhaps because that could be construed as promoting the drug for an off-label use. The study, published in the Journal of the American Medical Association, will take care of that--with the help of all the attendant media attention. Including ours.

- check out the article from the Washington Post

Related Articles:
Compound found for reducing alcohol dependence. Report
Drug companies focusing on ending alcohol abuse. Report
Topamax approved for new indication. Report

Read more on: Johnson & Johnson


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about FDA approval   Johnson & Johnson